Kangstem Biotech Co Ltd Sustainability Reports

Kangstem Biotech Co., Ltd. develops and manufactures umbilical cord blood-derived stem cell therapeutic products targeted at rare and incurable diseases. Its product pipelines focus on therapies for conditions such as atopic dermatitis, rheumatoid arthritis, and Crohn's disease.

Sector: Manufacturing

Country: South Korea

Exchange: Korea Exchange (KOSDAQ)

FIGI: BBG001V09GS7

1 reports from 2024 to 2024

• Kangstem Biotech Co Ltd 2024 Business Report